Shkreli Investment Account Frozen, Current Value Unknown

When Federal authorities froze the $45 million account of vilified health care investor Martin Shkreli, they are likely to be keeping an eye on the account’s equity level closely as shares of his primary asset, KaloBios Pharmaceuticals, Inc., could fall significantly in value as criminal charges and lawsuits swirl around Shkreli, potentially implicating those around firm management to various degrees.

Federal authorities freeze Shkreli investment account

Court documents reveal that, as of January 6,...